SARS-CoV-2 Delta variant: a systematic review of transmissibility and severity in children

Objectives: To review the evidence of the transmissibility and severity of infection with the Delta variant of SARS-CoV-2 in children.Design: Systematic review. Data sources: PubMed, Embase, medRxiv, Web of Science, and WHO COVID database.Study selection: English language original articles, case rep...

Full description

Saved in:
Bibliographic Details
Published inGlobal biosecurity Vol. 4; no. 1
Main Authors Honeyman, Damian Alexander, Buisson, Elise, Hutchinson, Danielle, Kunasekaran, Mohana, Aagerup, Jannik, Chen, Xin, Moa, Aye, Hyde, Zoë
Format Journal Article
LanguageEnglish
Published Ubiquity Press Ltd 19.12.2022
University of New South Wales
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Objectives: To review the evidence of the transmissibility and severity of infection with the Delta variant of SARS-CoV-2 in children.Design: Systematic review. Data sources: PubMed, Embase, medRxiv, Web of Science, and WHO COVID database.Study selection: English language original articles, case reports, commentaries, and letters with relevant primary data, which examined evidence for the transmissibility and severity of infection with the Delta variant of SARS-CoV-2 in children.Methods: Five databases were searched for articles from the period October 2020 to March 2022. Reference lists of eligible studies and grey literature were hand searched for additional studies for inclusion. Articles that provided adequate epidemiological data including infection, transmission, or severity (including hospitalisation and death) with probable or confirmed cases of the Delta variant of SARS-CoV-2 in children (aged ≤9 years) and adolescents (aged 10 to 19 years) were included. Data were extracted for country of origin; participant characteristics (age and sex); sample size; vaccination status; and outcomes, including incidence, secondary attack rate, hospitalisation, ICU, and mortality. All included studies were assessed for bias using the Joanna Briggs Institute Critical Appraisal checklists.Results: 298 studies were found through database searching. After screening, 21 studies were included in the systematic review. Of the included studies, all were deemed to be of moderate to high quality, therefore all were included in the final analysis. Increased incidence was reported in two population studies in the USA and Australia during the period of Delta predominance. Age-related data were available for 14 studies and showed higher rates of infection in older children compared to younger children. Attack rates in educational settings were higher when an adult was the primary case. Data on severity were available from 12 studies and showed that severe disease remained rare, with increasing hospitalisation numbers in proportion to increasing paediatric cases. Vaccination was protective for severe disease, with studies in the United States, Israel and Europe showing less healthcare encounters, emergency department presentations and hospitalisations amongst vaccinated adolescents. Several studies pointed to educational and household settings as key sites for paediatric infection with the Delta variant.Conclusion: A growing proportion of COVID-19 cases were diagnosed in children during the study period due to increased transmissibility of the SARS-CoV-2 Delta variant, with an increasing number of outbreaks observed in household and educational settings likely attributed to low vaccine coverage among children. While severe disease remains uncommon, the impact of vaccination in both adults and adolescents has been shown to reduce paediatric hospitalisation rates.
AbstractList Objectives: To review the evidence of the transmissibility and severity of infection with the Delta variant of SARS-CoV-2 in children.Design: Systematic review. Data sources: PubMed, Embase, medRxiv, Web of Science, and WHO COVID database.Study selection: English language original articles, case reports, commentaries, and letters with relevant primary data, which examined evidence for the transmissibility and severity of infection with the Delta variant of SARS-CoV-2 in children.Methods: Five databases were searched for articles from the period October 2020 to March 2022. Reference lists of eligible studies and grey literature were hand searched for additional studies for inclusion. Articles that provided adequate epidemiological data including infection, transmission, or severity (including hospitalisation and death) with probable or confirmed cases of the Delta variant of SARS-CoV-2 in children (aged ≤9 years) and adolescents (aged 10 to 19 years) were included. Data were extracted for country of origin; participant characteristics (age and sex); sample size; vaccination status; and outcomes, including incidence, secondary attack rate, hospitalisation, ICU, and mortality. All included studies were assessed for bias using the Joanna Briggs Institute Critical Appraisal checklists.Results: 298 studies were found through database searching. After screening, 21 studies were included in the systematic review. Of the included studies, all were deemed to be of moderate to high quality, therefore all were included in the final analysis. Increased incidence was reported in two population studies in the USA and Australia during the period of Delta predominance. Age-related data were available for 14 studies and showed higher rates of infection in older children compared to younger children. Attack rates in educational settings were higher when an adult was the primary case. Data on severity were available from 12 studies and showed that severe disease remained rare, with increasing hospitalisation numbers in proportion to increasing paediatric cases. Vaccination was protective for severe disease, with studies in the United States, Israel and Europe showing less healthcare encounters, emergency department presentations and hospitalisations amongst vaccinated adolescents. Several studies pointed to educational and household settings as key sites for paediatric infection with the Delta variant.Conclusion: A growing proportion of COVID-19 cases were diagnosed in children during the study period due to increased transmissibility of the SARS-CoV-2 Delta variant, with an increasing number of outbreaks observed in household and educational settings likely attributed to low vaccine coverage among children. While severe disease remains uncommon, the impact of vaccination in both adults and adolescents has been shown to reduce paediatric hospitalisation rates.
Objectives: To review the evidence of the transmissibility and severity of infection with the Delta variant of SARS-CoV-2 in children. Design: Systematic review. Data sources: PubMed, Embase, medRxiv, Web of Science, and WHO COVID database. Study selection: English language original articles, case reports, commentaries, and letters with relevant primary data, which examined evidence for the transmissibility and severity of infection with the Delta variant of SARS-CoV-2 in children. Methods: Five databases were searched for articles from the period October 2020 to March 2022. Reference lists of eligible studies and grey literature were hand searched for additional studies for inclusion. Articles that provided adequate epidemiological data including infection, transmission, or severity (including hospitalisation and death) with probable or confirmed cases of the Delta variant of SARS-CoV-2 in children (aged ≤9 years) and adolescents (aged 10 to 19 years) were included. Data were extracted for country of origin; participant characteristics (age and sex); sample size; vaccination status; and outcomes, including incidence, secondary attack rate, hospitalisation, ICU, and mortality. All included studies were assessed for bias using the Joanna Briggs Institute Critical Appraisal checklists. Results: 298 studies were found through database searching. After screening, 21 studies were included in the systematic review. Of the included studies, all were deemed to be of moderate to high quality, therefore all were included in the final analysis. Increased incidence was reported in two population studies in the USA and Australia during the period of Delta predominance. Age-related data were available for 14 studies and showed higher rates of infection in older children compared to younger children. Attack rates in educational settings were higher when an adult was the primary case. Data on severity were available from 12 studies and showed that severe disease remained rare, with increasing hospitalisation numbers in proportion to increasing paediatric cases. Vaccination was protective for severe disease, with studies in the United States, Israel and Europe showing less healthcare encounters, emergency department presentations and hospitalisations amongst vaccinated adolescents. Several studies pointed to educational and household settings as key sites for paediatric infection with the Delta variant. Conclusion: A growing proportion of COVID-19 cases were diagnosed in children during the study period due to increased transmissibility of the SARS-CoV-2 Delta variant, with an increasing number of outbreaks observed in household and educational settings likely attributed to low vaccine coverage among children. While severe disease remains uncommon, the impact of vaccination in both adults and adolescents has been shown to reduce paediatric hospitalisation rates.
Objectives: To review the evidence of the transmissibility and severity of infection with the Delta variant of SARS-CoV-2 in children. Design: Systematic review. Data sources: PubMed, Embase, medRxiv, Web of Science, and WHO COVID database. Study selection: English language original articles, case reports, commentaries, and letters with relevant primary data, which examined evidence for the transmissibility and severity of infection with the Delta variant of SARS- CoV- 2 in children. Methods: Five databases were searched for articles from the period October 2020 to March 2022. Reference lists of eligible studies and grey literature were hand searched for additional studies for inclusion. Articles that provided adequate epidemiological data including infection, transmission, or severity (including hospitalisation and death) with probable or confirmed cases of the Delta variant of SARS-CoV-2 in children (aged [less than or equal to] 9 years) and adolescents (aged 10 to 19 years) were included. Data were extracted for country of origin; participant characteristics (age and sex); sample size; vaccination status; and outcomes, including incidence, secondary attack rate, hospitalisation, ICU, and mortality. All included studies were assessed for bias using the Joanna Briggs Institute Critical Appraisal checklists. Results: 298 studies were found through database searching. After screening, 21 studies were included in the systematic review. Of the included studies, all were deemed to be of moderate to high quality, therefore all were included in the final analysis. Increased incidence was reported in two population studies in the USA and Australia during the period of Delta predominance. Age-related data were available for 14 studies and showed higher rates of infection in older children compared to younger children. Attack rates in educational settings were higher when an adult was the primary case. Data on severity were available from 12 studies and showed that severe disease remained rare, with increasing hospitalisation numbers in proportion to increasing paediatric cases. Vaccination was protective for severe disease, with studies in the United States, Israel and Europe showing less healthcare encounters, emergency department presentations and hospitalisations amongst vaccinated adolescents. Several studies pointed to educational and household settings as key sites for paediatric infection with the Delta variant. Conclusion: A growing proportion of COVID-19 cases were diagnosed in children during the study period due to increased transmissibility of the SARS-CoV-2 Delta variant, with an increasing number of outbreaks observed in household and educational settings likely attributed to low vaccine coverage among children. While severe disease remains uncommon, the impact of vaccination in both adults and adolescents has been shown to reduce paediatric hospitalisation rates. Key words: COVID-19, SARS-CoV-2 Delta variant, paediatric, infection, vaccination
Study selection: English language original articles, case reports, commentaries, and letters with relevant primary data, which examined evidence for the transmissibility and severity of infection with the Delta variant of SARS- CoV- 2 in children.
Audience Academic
Author Honeyman, Damian Alexander
Kunasekaran, Mohana
Chen, Xin
Hyde, Zoë
Hutchinson, Danielle
Moa, Aye
Buisson, Elise
Aagerup, Jannik
Author_xml – sequence: 1
  givenname: Damian Alexander
  orcidid: 0000-0002-4339-1801
  surname: Honeyman
  fullname: Honeyman, Damian Alexander
– sequence: 2
  givenname: Elise
  surname: Buisson
  fullname: Buisson, Elise
– sequence: 3
  givenname: Danielle
  surname: Hutchinson
  fullname: Hutchinson, Danielle
– sequence: 4
  givenname: Mohana
  surname: Kunasekaran
  fullname: Kunasekaran, Mohana
– sequence: 5
  givenname: Jannik
  surname: Aagerup
  fullname: Aagerup, Jannik
– sequence: 6
  givenname: Xin
  surname: Chen
  fullname: Chen, Xin
– sequence: 7
  givenname: Aye
  surname: Moa
  fullname: Moa, Aye
– sequence: 8
  givenname: Zoë
  orcidid: 0000-0002-5985-1729
  surname: Hyde
  fullname: Hyde, Zoë
BookMark eNptUU1rGzEQFcGFJmkO_QeCnHJYVx-70io34zapwRBI2h56EbPakSOzXhVpcfC_rxKH0EKYw3zw5s083hmZjXFEQj5zNpdc1erLpgtxzpU5IadCNaJiTKrZP_VHcpHzljEmWs5Yw07J74fF_UO1jL8qQb_iMAHdQwowTtcUaD7kCXcwBUcT7gM-0ejplGDMu5Bz6MIQpgOFsacZ95iemzBS9xiGPuH4iXzwMGS8eM3n5OfNtx_L79X67na1XKwrJ7QwlVeNZE520mngrqhgRje1FEKrthNcGCm90FCDRvSIrEHdaKm1h77tpDLynKyOvH2Erf2Twg7SwUYI9mUQ08ZCKhoGtEqrvkMP2tddbbg3iJ0XhkPLjPIeC9flkWsDBR5GH4tcV9Q6uyhHZSsZrwtq_g6qRI-74IonPpT5fwtXxwWXYs4J_dubnNkX6-yzdbZYJ_8CDwqL0Q
ContentType Journal Article
Copyright COPYRIGHT 2022 Ubiquity Press Ltd.
Copyright_xml – notice: COPYRIGHT 2022 Ubiquity Press Ltd.
DBID AAYXX
CITATION
DOA
DOI 10.31646/gbio.169
DatabaseName CrossRef
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
DatabaseTitleList CrossRef



Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
DeliveryMethod fulltext_linktorsrc
EISSN 2652-0036
ExternalDocumentID oai_doaj_org_article_676dbefa7f4b491f9eebf291a8096ffe
A737383014
10_31646_gbio_169
GeographicLocations Australia
United Kingdom
GeographicLocations_xml – name: United Kingdom
– name: Australia
GroupedDBID AAPRH
AAYXX
ADBBV
ALMA_UNASSIGNED_HOLDINGS
BCNDV
CITATION
GROUPED_DOAJ
H13
IAO
ICD
ITC
M~E
ID FETCH-LOGICAL-c2729-f6530c3b3c7a1c64609754322768b212933f27a4a7eefee05e757377fad8b3693
IEDL.DBID DOA
ISSN 2652-0036
IngestDate Wed Aug 27 01:30:39 EDT 2025
Wed Mar 19 16:52:15 EDT 2025
Tue Mar 18 03:43:24 EDT 2025
Tue Jul 01 02:44:26 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License https://creativecommons.org/licenses/by/4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c2729-f6530c3b3c7a1c64609754322768b212933f27a4a7eefee05e757377fad8b3693
ORCID 0000-0002-5985-1729
0000-0002-4339-1801
OpenAccessLink https://doaj.org/article/676dbefa7f4b491f9eebf291a8096ffe
ParticipantIDs doaj_primary_oai_doaj_org_article_676dbefa7f4b491f9eebf291a8096ffe
gale_infotracmisc_A737383014
gale_infotracacademiconefile_A737383014
crossref_primary_10_31646_gbio_169
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20221219
PublicationDateYYYYMMDD 2022-12-19
PublicationDate_xml – month: 12
  year: 2022
  text: 20221219
  day: 19
PublicationDecade 2020
PublicationTitle Global biosecurity
PublicationYear 2022
Publisher Ubiquity Press Ltd
University of New South Wales
Publisher_xml – name: Ubiquity Press Ltd
– name: University of New South Wales
SSID ssj0002810050
Score 2.2054856
Snippet Objectives: To review the evidence of the transmissibility and severity of infection with the Delta variant of SARS-CoV-2 in children.Design: Systematic...
Objectives: To review the evidence of the transmissibility and severity of infection with the Delta variant of SARS-CoV-2 in children. Design: Systematic...
Study selection: English language original articles, case reports, commentaries, and letters with relevant primary data, which examined evidence for the...
SourceID doaj
gale
crossref
SourceType Open Website
Aggregation Database
Index Database
SubjectTerms Analysis
Australia
Children
covid-19
Database searching
Disease transmission
Epidemiology
Health aspects
Infection
Internet/Web search services
Medical research
Medicine, Experimental
Mortality
Online searching
paediatric
sars-cov-2 delta strain
United Kingdom
Vaccination
Title SARS-CoV-2 Delta variant: a systematic review of transmissibility and severity in children
URI https://doaj.org/article/676dbefa7f4b491f9eebf291a8096ffe
Volume 4
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1BS8MwFA6ykxdRVJxOCSJ4ilubpmm8zbkhwjw4J8NLSNpEJtKKVMGLv9332k7ryYtQemgfJf1eX977St4XQk4ERFhmjWLSppZFMuHMeGGYFc7GQZIJVck1TW_iq3l0vRCL1lZfuCaslgeugevH-CznjfSRjVTglXPWhyowCRTf3jucfSHntcjUU_XLKEBlk1pKiKOGVv_RLouzABc2txJQpdPfzMatvDLZJBtNQUiH9UC2yJrLt8nDbHg7Y6PinoX00j2Xhr4DpwUQzqmhP-LLtG48oYWnJeYc8Fmz2vWDmjyjkPUcbk5HlzlddW3vkPlkfDe6Ys0uCCwNofJlPhZ8kHLLU2mCFN5koKSIIA6BKNgQ0zX3oTSRkc555wbCSSG5lN5kieWx4rukkxe52yM0FlkWhT5wkQTW5Q3UJmAAfFRyYb0Ku-R4BY1-qcUuNJCECj-N-GnAr0suELRvA9Snri6A13TjNf2X17rkFCHXGEUAUGqaZgAYJ-pR6aFExSWke13S-2UJSKat2_v_MZoDsh5iV0MAh-qRTvn65g6h1ijtUfVZwXn6Of4ChmrUdg
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=SARS-CoV-2+Delta+variant%3A+a+systematic+review+of+transmissibility+and+severity+in+children&rft.jtitle=Global+biosecurity&rft.au=Honeyman%2C+Damian&rft.au=Buisson%2C+Elise&rft.au=Hutchinson%2C+Danielle&rft.au=Kunasekaran%2C+Mohana&rft.date=2022-12-19&rft.pub=Ubiquity+Press+Ltd&rft.issn=2652-0036&rft.eissn=2652-0036&rft.volume=4&rft.issue=1&rft_id=info:doi/10.31646%2Fgbio.169&rft.externalDocID=A737383014
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2652-0036&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2652-0036&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2652-0036&client=summon